Table: begin end state 1 18 cytoplasmic 19 44 transmembrane 45 52 non-cytoplasmic 53 78 transmembrane 79 85 cytoplasmic 86 107 transmembrane 108 113 non-cytoplasmic 114 142 transmembrane 143 161 cytoplasmic 162 179 transmembrane 180 186 non-cytoplasmic 187 206 transmembrane 207 243 cytoplasmic 244 265 transmembrane 266 276 non-cytoplasmic 277 299 transmembrane 300 309 cytoplasmic 310 329 transmembrane 330 337 non-cytoplasmic 338 361 transmembrane 362 372 cytoplasmic 373 397 transmembrane 398 402 non-cytoplasmic 403 423 transmembrane 424 432 cytoplasmic
Input: >RR42_RS19610 MPQVHEISKAQRRKAILAATIGNGLEWFDFTVYSFFALIIAKLFFPTGNDLTSFLLTVAT FGVGFFMRPVGAIVLGVYADRVGRKAALTLTILMMALGTAIIGLAPTYSSIGLWAPALIV LARLIQGFSAGGEVGGATAFLIEHAPDEERGAYASWQQASQGISFMLGAAMGALVINGLE PEQIDAWGWRIPFLFGLLIGPVGMYIRSHLEEPPAFEARRAERAASKVKFSPLTQVLRDH PREVLAGLGVTILWTVCTYVLVFYMPSYAKQQLGLPLGATFQSTALCGAIILVLCPLMGM LSDRVGRKRMLGTVALIIGVLAYPLFHWLNVSPTTQTLLMVQVILGILLAAFTGPAPAVL AEQFPTEVRSTGLSLAYNFAVTIFGGFAPLIVTWLIASSGSKLAPAYYVIAAAAISFVAL LFMHDRTGKPLQ
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server